{"name":"Induce Biologics USA Inc.","slug":"induce-biologics-usa-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOSEo3dkxZRU52R1dHSVJjbUNsdEJfZFNNNWtHM0pMSnduMWlZMUpIOWhEcnA3X0ExYTR4azcxYVhoalFzYUNpbFIzOVVDMjJFXzNGVkJiTkx2TXViQTFhWnQxM19xanNfZ2gwQ3lDNUZoeFhyQmhBV3FvYjBIM3U4VTNmeElhVWFSbXl1NXdCbi1fTG5MNzVXNHB4Qm43NWhjeUNXdVZ2M1pCdF9PUTRDYUU2V3NGWm1CTUE?oc=5","date":"2025-12-30","type":"regulatory","source":"Ultragenyx","summary":"Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa) - Ultragenyx","headline":"Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy f","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-25","type":"regulatory","source":"PR Newswire","summary":"Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Di","headline":"Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Appli","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPbHE0Mm9YMGxVUkZ3dDZDNDA1Wnl1VndPOTBZSWNhQ19zbE1NMjA5TDJnc3pEdHR1Mnd5WU5UV1JlSEFQVWI2a1EwNVVjNmx6MV9yajVaZjRqbHRFdEtLdndHVEM4dVVvTEpaaVFlYjF6cHhzLXBvcVdCMDlyMGZqRjFMZ3k3Vk9DbWNDV2tiRU9kN3hjLS14Qk9vaU1pay1vX0ROZmlkenZ6akgwM3hMTzFHcGEtYldmSHVIQmpvME50NjctWFpv?oc=5","date":"2025-06-12","type":"pipeline","source":"UCB","summary":"UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity - UCB","headline":"UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNdmRUdThGdGF3bnBKZF8yV1JrN3BvTUJWbXZKZUN4VVh2T3JmTUUyZG5HcDJlNDRNWjhtNGJSU1VFbDhfLTV3M3JaanlWMFBjcjlDX0tJeDNWR05XZV85ekltMTBmemp6RGdDa0FSdzF5bUc5UjE4eDN4WGNyeUFzQnNheEJYZDFJbk9tRzRIZ1M2eXVzRC14R0VLUjlyZkM1UkNxOUZiU1BhM3hQa0JTUG96Z1hGUDNxdDkybVRGSWQ?oc=5","date":"2025-05-16","type":"pipeline","source":"KFF Health News","summary":"Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs - KFF Health News","headline":"Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPaXRSYXhaZTJSWWExaHRHYzh6QzRhb21sUzJ0X0xPWVpUQW5nZVU2emV3QWRnM2dpZWJ1Ni1MVDlEb3NtNzgxRFZ5WEtqNVFrYWhodEk1RGhSRXlsQm5ZNHVTbXBVSjBTMzhGNERjR3BlcDJFMFAzbDJHNU1wLUp0b0JkQ2lXSkxzZEFUaVRDSE5Jdld6MDRIMUg5YWstVjFpQlJIWVJrVkQwUQ?oc=5","date":"2020-03-10","type":"pipeline","source":"Fierce Pharma","summary":"New CEO takes over as Fujifilm Diosynth Biotechnologies expands - Fierce Pharma","headline":"New CEO takes over as Fujifilm Diosynth Biotechnologies expands","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBIXzM4ZVp4RTRFUVFKeFVWN1NVUjJUTklfZWIwczNWNFFRVXRiaHhOd09HaWd2UlZMY2FGazNFanZBUnlaTW5fUjVGX3RZR3RRLTNhY050SXJVM2Jab3BqS0xiTDhMakFKZFJlZy1LTG1iTmZhZlo4?oc=5","date":"2016-03-06","type":"pipeline","source":"Grand View Research","summary":"Biologics Market Size, Share & Growth Analysis Report, 2030 - Grand View Research","headline":"Biologics Market Size, Share & Growth Analysis Report, 2030","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}